Daily High to Daily Low: Is It Safe to Buy Karyopharm Therapeutics Inc. (KPTI)? [unable to retrieve full-text content] … Cancer Network(R) Adds Three XPOVIO(R) (selinexor) Treatment Regimens to Its Clinical Practice Guidelines in Oncology for Multiple Myeloma …Published at Tue, 15 Dec 2020 08:25:01 +0000
Read More
The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020. The market has been analyzed on the basis of […]
Read More
Without research work, it is impossible to learn and match the technological expertise of the global standards. We are already lacking behind in the new innovations and researches as compared to other developing countries. This effort will only be realized when the institutions will take the research work as of utmost importance. While doing higher […]
Read More Acibadem Continues Breakthrough Pancreatic Cancer Treatments in Turkey In the interview, Prof. Ceyhan, a doctor at Acibadem Maslak and Altunizade Hospital, reviewed treatment methodologies available for cancer patients afflicted with one of the most dangerous forms of the disease. Worldwide, nearly 250,000 new patients were diagnosed with malignant tumors affecting the pancreas in 2018. Due […]
Read More
Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancer Daiichi Sankyo and AstraZeneca could be just weeks away from an EU approval for their antibody-drug conjugate (ADC) for breast cancer – Enhertu – which is tipped to become a multibillion-dollar blockbuster. At its meeting last week, the EMA’s Committee for Medicinal Products […]
Read More
Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid Cipla rose 3.70% to Rs 783.85 after the drug major announced the settlement of its litigation with Celgene Corporation relating to patents for Revlimid (lenalidomide). In the US, Revlimid (lenalidomide) in combination with dexamethasone is indicated for the treatment of patients with multiple […]
Read More
Analysts Expect Sutro Biopharma, Inc. (NASDAQ:STRO) Will Announce Quarterly Sales of $12.60 … Equities analysts expect that Sutro Biopharma, Inc. (NASDAQ:STRO) will post $12.60 million in sales for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Sutro Biopharma’s earnings, with estimates ranging from $7.00 million to $19.54 million. Sutro Biopharma reported […]
Read More
First Covid Vaccines’ Triumph Raises Hope for Cancer Fight Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis. The first vaccines against Covid-19 aren’t just a landmark in the fight against the pandemic. They’re also the stepping stone […]
Read More
A donation was used to establish a new cancer research laboratory When a rarer form of cancer competes for funding against more common cancer types, the rarer form is often overshadowed. According to Professor Heikki Joensuu, the number of such rare but dangerous cancers is nevertheless high – one of them is aggressive soft-tissue sarcoma of […]
Read More
GSRGT 2020: The Global Voice of Penile Cancer Research: The International Registry (UroToday.com) The Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit included an update on the international registry for penile cancer provided by Dr. Marco Bandini from San Raffaele Hospital in Milan, Italy. According to Dr. Bandini, there are several important questions under […]
Read More